ARE Patent Law Alert:
USPTO Issues Final Rules For Implementing New Post-Issuance Patent Validity Proceedings Effective On September 16, 2012

(September 4, 2012)  Among the significant changes to the U.S. patent laws made by the America Invents Act are the introduction of new procedures for challenging the validity of issued patents before the U.S. Patent and Trademark Office (“USPTO”).  These new procedures are designed to permit petitioners to bring speedy challenges to patent validity in […]

ARE Patent Law Alert:
On Remand, Federal Circuit Maintains Previous Holding That Isolated DNA Is Patent-Eligible But Methods Of Comparing Or Analyzing Isolated DNA Are Patent-Ineligible

(August 16, 2012)  On August 16, 2012, the Federal Circuit released its highly anticipated decision in Ass’n for Molecular Pathology v. USPTO and Myriad Genetics, No. 2010-1406 (Fed. Cir. August 16, 2012) (“Myriad”), on remand from the U.S. Supreme Court, concerning the patent-eligibility of isolated DNA under 35 U.S.C. § 101. The patents at issue […]

ARE Patent Law Alert:
Federal Circuit Affirms Computer-Implemented Financial Management Claims Patent-Ineligible As Capable Of Being Performed Mentally

(July 30, 2012)  Just a few weeks after its decision in CLS Bank Int’l v. Alice Corp. Pty. Ltd., No. 2011-1301, 2012 U.S. App. LEXIS 13973 (Fed. Cir. July 9, 2012) recently reported by us, the Federal Circuit again considered the patent-eligibility of claims covering computer-implemented financial management systems, methods, and media.  This time the […]